Gastroenterology
Volume 135, Issue 6 , Pages 1914-1923.e1 , December 2008

Thiazolidinedione Therapy Is Not Associated With Increased Colonic Neoplasia Risk in Patients With Diabetes Mellitus

  • James D. Lewis

      Affiliations

    • Department of Medicine, Division of Gastroenterology, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • Corresponding Author InformationAddress requests for reprints to: James D. Lewis, MD, MSCE, 720 Blockley Hall, 423 Guardian Drive, Philadelphia, Pennsylvania 19104-6021. fax: (215) 573-0813
    • ,
  • Angela M. Capra

      Affiliations

    • Division of Research, Kaiser Permanente Northern California, Oakland, California
    • ,
  • Ninah S. Achacoso

      Affiliations

    • Division of Research, Kaiser Permanente Northern California, Oakland, California
    • ,
  • Assiamira Ferrara

      Affiliations

    • Division of Research, Kaiser Permanente Northern California, Oakland, California
    • ,
  • Theodore R. Levin

      Affiliations

    • Division of Research, Kaiser Permanente Northern California, Oakland, California
    • ,
  • Charles P. Quesenberry Jr

      Affiliations

    • Division of Research, Kaiser Permanente Northern California, Oakland, California
    • ,
  • Laurel A. Habel

      Affiliations

    • Division of Research, Kaiser Permanente Northern California, Oakland, California

Received 16 May 2008 ,Accepted 4 September 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The authors disclose the following: Supported by NIH grant CA102599. Drs Lewis, Habel, Ferrara, and Quesenberry have received research funding from Takeda. Dr Lewis has received research support from GlaxoSmithKline. Drs Habel and Ferrara have received research support from Eli Lilly. Dr Habel has also received research support from Merck.

PII: S0016-5085(08)01667-3

doi: 10.1053/j.gastro.2008.09.004

Gastroenterology
Volume 135, Issue 6 , Pages 1914-1923.e1 , December 2008

Article Tools

* Image Usage & Resolution